Evaluate the Efficacy and Safety of D-0120 in Primary Hyperuricemia Patients
Clinical trial NCT05504083 · COMPLETED
Trial details
- NCT number
- NCT05504083
- Sponsor
- InventisBio Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-28
- Primary completion
- 2024-05-18
- Enrollment
- 121
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.